## Core Concept
The question tests knowledge of pharmacokinetics, specifically half-life, of various statins. Statins are a group of cholesterol-lowering medications that inhibit **HMG-CoA reductase**, a key enzyme in cholesterol synthesis. The half-life of a drug is crucial in determining its dosing interval and potential for accumulation.

## Why the Correct Answer is Right
**Rosuvastatin** has a half-life of approximately 19 hours, which is one of the longest among statins. This longer half-life allows for once-daily dosing and contributes to its efficacy in managing cholesterol levels. Rosuvastatin's mechanism involves potent inhibition of **HMG-CoA reductase**, and its pharmacokinetic profile supports its use in a wide range of patients, including those with high cardiovascular risk.

## Why Each Wrong Option is Incorrect
- **Option A (Atorvastatin):** Atorvastatin has a half-life of about 14 hours, which, although long enough for once-daily dosing, is shorter than that of rosuvastatin.
- **Option B (Simvastatin):** Simvastatin has a relatively short half-life of approximately 3 hours, necessitating multiple daily doses or a sustained-release formulation for better compliance.
- **Option C (Pravastatin):** Pravastatin's half-life is around 2-3 hours, which is one of the shortest among statins, making it less favorable for once-daily dosing compared to rosuvastatin.

## Clinical Pearl / High-Yield Fact
A key clinical pearl is that statins with longer half-lives, like **rosuvastatin**, tend to have more potent effects on lowering LDL cholesterol and may offer better patient compliance due to their once-daily dosing regimen.

## Correct Answer: D. Rosuvastatin